DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients (NCT07290608) | Clinical Trial Compass
CompletedNot Applicable
DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients
Brazil59 participantsStarted 2025-01-20
Plain-language summary
Study using a decision algorithm for the application of an oral anticoagulant calculator in vascular diseases, aimed at validating a clinical decision-support tool for conditions such as deep vein thrombosis, superficial thrombophlebitis, and pulmonary thromboembolism.
Who can participate
Age range
18 Years – 89 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
* Physicians with residency training in Vascular Surgery or official Board Certification in Vascular Surgery.
* Currently practicing clinical and/or surgical vascular care in Brazil.
* Completed the informed consent process (TCLE) and voluntarily agreed to participate.
Exclusion Criteria
* Physicians without formal Vascular Surgery residency and without Board Certification.
* Physicians not performing vascular clinical or surgical care (e.g., exclusively administrative, academic, or non-assistance roles).
* Less than 1 year of professional experience after medical school graduation.
* Did not sign or did not fully complete the TCLE.
Large Language Models (LLMs)
* Inclusion Criteria
* Free-access LLMs available to the public at the time of data collection.
* All responses generated using the same standardized prompt.
* Capable of producing complete, text-based clinical answers relevant to vascular surgery decision-making.
Exclusion Criteria
* Paid or subscription-based LLMs.
* LLMs requiring institutional licenses, restricted access, or proprietary tokens.
* Models unable to generate full responses to the standardized prompt.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Accuracy of the DOACT Algorithm in Guiding Oral Anticoagulant Therapy